These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 31230034

  • 1. Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study.
    Kim SJ, Kwon OD, Cho B, Oh SW, Lee CM, Choi HC.
    BMJ Open; 2019 Jun 22; 9(6):e029862. PubMed ID: 31230034
    [Abstract] [Full Text] [Related]

  • 2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Jun 22; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 3. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs.
    Wang TD, Chen YH, Huang CH, Chen WJ, Chen MF.
    Hypertension; 2014 May 22; 63(5):958-67. PubMed ID: 24446059
    [Abstract] [Full Text] [Related]

  • 4. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens.
    Zeng F, Patel BV, Andrews L, Frech-Tamas F, Rudolph AE.
    Curr Med Res Opin; 2010 Dec 22; 26(12):2877-87. PubMed ID: 21067459
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
    Rea F, Morabito G, Savaré L, Pathak A, Corrao G, Mancia G.
    J Hypertens; 2023 Sep 01; 41(9):1466-1473. PubMed ID: 37432906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study.
    Kim SJ, Kwon OD, Han EB, Lee CM, Oh SW, Joh HK, Oh B, Kwon H, Cho B, Choi HC.
    Medicine (Baltimore); 2019 Dec 01; 98(49):e17825. PubMed ID: 31804305
    [Abstract] [Full Text] [Related]

  • 9. Single-pill combination for treatment of hypertension: Just a matter of practicality or is there a real clinical benefit?
    Coca A, Whelton SP, Camafort M, López-López JP, Yang E.
    Eur J Intern Med; 2024 Aug 01; 126():16-25. PubMed ID: 38653633
    [Abstract] [Full Text] [Related]

  • 10. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC, Tung YC, Chou SH, Wu LS, Lin CP, Wang CL, Lin YS, Chang CJ, Chu PH.
    Medicine (Baltimore); 2015 Dec 01; 94(51):e2355. PubMed ID: 26705234
    [Abstract] [Full Text] [Related]

  • 11. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr 01; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 12. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
    Lu Y, Van Zandt M, Liu Y, Li J, Wang X, Chen Y, Chen Z, Cho J, Dorajoo SR, Feng M, Hsu MH, Hsu JC, Iqbal U, Jonnagaddala J, Li YC, Liaw ST, Lim HS, Ngiam KY, Nguyen PA, Park RW, Pratt N, Reich C, Rhee SY, Sathappan SMK, Shin SJ, Tan HX, You SC, Zhang X, Krumholz HM, Suchard MA, Xu H.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223877. PubMed ID: 35323951
    [Abstract] [Full Text] [Related]

  • 13. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, Park JI, Lee WS.
    Clin Transl Sci; 2021 May 01; 14(3):1185-1192. PubMed ID: 33503302
    [Abstract] [Full Text] [Related]

  • 14. The association of angiotensin receptor blocker-based combination therapy with persistence and adherence in newly treated, uncomplicated hypertensive patients.
    Ah YM, Shin J, Lee JY.
    Patient Prefer Adherence; 2019 May 01; 13():241-248. PubMed ID: 30774320
    [Abstract] [Full Text] [Related]

  • 15. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients.
    Panjabi S, Lacey M, Bancroft T, Cao F.
    J Am Soc Hypertens; 2013 May 01; 7(1):46-60. PubMed ID: 23321404
    [Abstract] [Full Text] [Related]

  • 16. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
    Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM.
    PLoS Med; 2018 Jun 01; 15(6):e1002584. PubMed ID: 29889841
    [Abstract] [Full Text] [Related]

  • 17. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 01; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 18. Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.
    Ishida T, Oh A, Nishigaki N, Tsuchihashi T.
    Geriatr Gerontol Int; 2019 Nov 01; 19(11):1077-1083. PubMed ID: 31436025
    [Abstract] [Full Text] [Related]

  • 19. Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.
    Tung YC, Huang YC, Wu LS, Chang CJ, Chu PH.
    J Clin Hypertens (Greenwich); 2017 Oct 01; 19(10):983-989. PubMed ID: 28560786
    [Abstract] [Full Text] [Related]

  • 20. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
    Hiroi S, Shimasaki Y, Kikuchi T, Otsuka Y, Iwasaki K, Ohishi M.
    Hypertens Res; 2016 Dec 01; 39(12):907-912. PubMed ID: 27465576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.